¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"mixed receptive-expressive language disorder"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • intestinal motility disorder
    âÀڿÀå¾Ö, Àå¿îµ¿Àå¾Ö
  • learning disorder
    ÇнÀÀå¾Ö
  • lymphoproliferative disorder
    ¸²ÇÁ¼¼Æ÷Áõ½ÄÁúȯ
  • micturition disorder
    ¹è´¢Àå¾Ö
  • malabsorptive disorder
    Èí¼öÀå¾ÖÁúȯ
  • minor depressive disorder
    °æµµ¿ì¿ïÀå¾Ö
  • mitochondrial disorder
    »ç¸³Ã¼Áúȯ, ¹ÌÅäÄܵ帮¾ÆÁúȯ
  • mood disorder
    ±âºÐÀå¾Ö
  • multifactorial genetic disorder
    ´ÙÀÎÀÚÀ¯ÀüÁúȯ
  • multiple personality disorder
    ´ÙÁßÀΰÝÀå¾Ö
  • myelodysplastic disorder
    °ñ¼öÇü¼ºÀÌ»óÁúȯ, °ñ¼öÇü¼ºÀå¾Ö
  • myeloproliferative disorder
    °ñ¼öÁõ½ÄÁúȯ
  • myopathic disorder
    ±Ù(À°)º´Áõ
  • mendelian disorder
    ¸àµ¨À¯ÀüÁúȯ
  • menstrual disorder
    ¿ù°æÀå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • lymphoproliferative disorder
    ¸²ÇÁ¼¼Æ÷Áõ½ÄÁúȯ
  • major affective disorder
    ÁÖ¿äÁ¤µ¿Àå¾Ö, ÁÖ¿äÁ¤µ¿º´
  • malabsorptive disorder
    Èí¼öÀå¾ÖÁúȯ
  • mendelian disorder
    ¸àµ¨À¯ÀüÁúȯ
  • menstrual disorder
    ¿ù°æÀå¾Ö
  • mental disorder
    Á¤½ÅÀå¾Ö, Á¤½Åº´
  • metabolic disorder
    ´ë»çÀå¾Ö
  • micturition disorder
    ¹è´¢Àå¾Ö
  • minor depressive disorder
    °æÁõ¿ì¿ïÀå¾Ö
  • mood disorder
    ±âºÐÀå¾Ö, ±âºÐº´
  • motor neuron disorder
    ¿îµ¿½Å°æ¼¼Æ÷Àå¾Ö
  • multifactorial genetic disorder
    ´ÙÀμºÀ¯ÀüÀå¾Ö, ´ÙÀμºÀ¯ÀüÁúȯ
  • multiple personality disorder
    ´ÙÁßÀΰÝÀå¾Ö
  • myelodysplastic disorder
    °ñ¼öÇü¼ºÀÌ»óÁúȯ
  • myeloproliferative disorder
    °ñ¼öÁõ½ÄÁúȯ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • reactive attachment disorder
    ¹ÝÀÀ¼º ¾ÖÂø(äñó·)Àå¾Ö(º´)
  • recurrent brief depressive disorder
    Àç¹ß¼º ´Ü±â¿ì¿ïÀå¾Ö(º´)
  • renal disorder
    ½ÅÀå¾Ö(ãìî¡äô).
  • renal disorder
    ½ÅÀå¾Ö(ãìî¡äô)
  • renal vascular disorder
    ½ÅÇ÷°üÁúȯ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • mixed nerve
    È¥ÇսŰæ(ûèùêãêÌè).
  • mixed nerve
    È¥ÇսŰæ
  • mixed nystagmus
    È¥ÇÕ¾ÈÁø
  • mixed odontoma
    È¥ÇÕ¼º Ä¡¾ÆÁ¾(¡­àõöÍä³ðþ).
  • mixed order reaction
    È¥ÇÕÂ÷¹ÝÀÀ(ûèùêó­ Úãëë).
  • mixed pattern
    È¥ÇÕ ¾ç»ó
  • mixed porphyria
    º¹ÇÕ Æ÷¸£ÇǸ°Áõ
  • mixed psychosis
    È¥À缺Á¤½ÅÁõ(ûèî¤àõïñãêñø).
  • mixed saliva
    È¥ÇÕŸ¾×(¡­öääû).
  • mixed saliva
    È¥ÇÕŸ¾×
  • mixed salivary gland
    º¹ÇÕħ»ù, È¥ÇÕŸ¾×¼± (¡­àÍ).
  • mixed salivary gland
    È¥ÇÕŸ¾×¼±, º¹ÇÕħ»ù
  • mixed sequence
    º¹ÇÕ ¿¬¼â
  • mixed small and large cell lymphoma
    È¥ÇÕ¼º ´ë¼Ò¼¼Æ÷ ¸²ÇÁÁ¾(¡­ ÓÞá³á¬øà ¡­ðþ)
  • mixed spicule
    È¥ÇÕħ°ñ(ûèùêöÜÍé).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
MCTD Mixed Connective Tissue Disease
MEOS Microsomal Ethanol Oxidizing System
  = MFOS; Mixed Function Oxidase System
MLC   1) Minimal Lethal Concentration
  2) Mixed Lymphocyte Culture
NMLH Nodular Mixed Lymphocytic Histocytic
TAE Trans-Arterial(-Catheter) Embolization
  Angiography¿Í µ¿½Ã¿¡ Gel Form°ú CTx AgentÀÇ Mixed m...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
MLR Mixed leucocyte reaction
MLK mixed lineage kinase
MLC Mixed lymphocyte culture
MLR Mixed lymphocyte reaction
MLR Mixed lymphocyte reactivity
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • muscle disorder
    ±ÙÀ° Àå¾Ö, ±Ù Àå¾Ö
  • muscle origin disorder
    ±ÙÀ°¼º Àå¾Ö
  • muscular disorder
    ±ÙÀ° Àå¾Ö
  • musculoskeletal pain disorder
    ±Ù °ñ°Ý¼º µ¿Åë Àå¾Ö
  • myalgic disorder
    ±ÙÀ°Åë Àå¾Ö
  • myogenous pain disorder
    ±ÙÀ°¼º µ¿Åë Àå¾Ö
  • nervous disorder
    ½Å°æ Àå¾Ö
    µ¿ÀǾî=nervous disturbance.
  • neurologic disorder
    ½Å°æÇÐÀû Áúȯ, ½Å°æ Àå¾Ö
  • neuromuscular disorder
    ±Ù½Å°æ°è Áúȯ, ±Ù½Å°æ Àå¾Ö, ½Å°æ±Ù Áúȯ
  • neuropathic disorder
    ½Å°æ Àå¾Ö
  • neuropathic pain disorder
    ½Å°æ¼º µ¿Åë Àå¾Ö, ½Å°æº´¼º µ¿Åë Àå¾Ö
  • neuropsychological disorder
    ½Å°æ ½É¸®Àû Àå¾Ö
  • neurotic disorder
    ½Å°æÁõÀû Àå¾Ö
  • neurovascular disorder
    ½Å°æ Ç÷°ü Àå¾Ö
  • non-vascular intracranial disorder
    ºñÇ÷°ü¼º µÎ°³³» Àå¾Ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
conversion disorder A disorder whose predominant feature is a loss or alteration in physical functioning that suggests a physical disorder but that is actually a direct expression of a psychological conflict or need.
(12 Dec 1998)
polygenic disorder <genetics> Genetic disorders resulting from the combined action of alleles of more thanone gene (for example, heart disease, diabetes, and some cancers). Although such disorders are inherited, they depend on the simultaneous presence of several alleles, thus the hereditary patterns are usually more complex than those of single-gene disorders.
(14 Oct 1997)
posttraumatic stress disorder Development of characteristic symptoms following a psychologically traumatic event that is generally outside the range of usual human experience; symptoms include numbed responsiveness to environmental stimuli, a variety of autonomic and cognitive dysfunctions, and dysphoria.
(05 Mar 2000)
cyclothymic disorder An affective disorder characterised by periods of depression and hypomania. These may be separated by periods of normal mood.
(12 Dec 1998)
cyclothymic personality disorder A personality disorder in which a person experiences regularly alternating periods of elation and depression, (see bipolar illness) usually not related to external circumstances or situation.
(27 Sep 1997)
Hartnup disorder <biochemistry> Amino acid transport defect that leads to excessive loss of monoamino monocarboxylic acids (cystine, lysine, ornithine, arginine) in the urine and poor absorption in the gut.
See: iminoglycinuria.
(18 Nov 1997)
heat stress disorder A group of conditions due to overexposure to or overexertion in excess environmental temperature.
It includes heat cramps, which are non-emergent and treated by salt replacement; heat exhaustion, which is more serious, treated with fluid and salt replacement; and heatstroke, a condition most commonly affecting extremes of age, especially the elderly, accompanied by convulsions, delusions, or coma and treated with cooling the body and replacement of fluids and salts.
(12 Dec 1998)
schizoid personality disorder An individual who is isolated, cold and indifferent.
(27 Sep 1997)
schizophreniform disorder A disorder whose essential features are identical with those of schizophrenia, with the exception that the duration including prodromal, active, and residual phases is less than six months.
(05 Mar 2000)
schizotypal personality disorder An individual who is eccentric with ideas, reference, magical thinking and suspicious.
(27 Sep 1997)
psychogenic pain disorder A disorder in which the principal complaint is pain that is out of proportion to objective findings and that is related to psychological factors.
(05 Mar 2000)
seasonal affective disorder A syndrome characterised by depressions that recur annually at the same time each year, usually during the winter months. Other symptoms include anxiety, irritability, decreased energy, increased appetite (carbohydrate cravings), increased duration of sleep, and weight gain. Sad (seasonal affective disorder) can be treated by daily exposure to bright artificial lights (phototherapy), during the season of recurrence.
(12 Dec 1998)
histrionic personality disorder An individual who is dramatic, engaging, self-centreed and attention seeking.
(27 Sep 1997)
psychosomatic disorder A disorder characterised by physical symptoms of psychic origin, usually involving a single organ system innervated by the autonomic nervous system; physiological and organic changes stem from a sustained disturbance.
(05 Mar 2000)
separation anxiety disorder A mental disorder occurring in childhood characterised by excessive anxiety when the child is separated from someone to whom the child is attached, usually a parent.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á